Press Releases for the Psychedelics Industry | Page 18 of 37

Psychedelics News

Press Releases

3 Mar 2021

REPEAT – Pure Extracts Orders Over 30,000 Vape Cartridges in Preparation for Retail Distribution

VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp....

By Microdose

Press Releases

3 Mar 2021

Ehave Inc. Files for KetaDash Trademark and to Uplist its Shares to the OTCQB

MIAMI, March 03, 2021 (GLOBE NEWSWIRE) — Ehave, Inc....

By Microdose

Press Releases

3 Mar 2021

Entheon Biomedical Announces Nancy Maher, Special Advisor of Data Science and Regulatory Affairs

By Microdose

Press Releases

3 Mar 2021

Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to Advisory Board

Vancouver, British Columbia–(Newsfile Corp....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

2 Mar 2021

PsyBio Therapeutics Initiates Pilot Scale Development of Proprietary Biosynthetic Psilocybin with Global Contract Research, Development and Manufacturing Organization

OXFORD, Ohio and COCONUT CREEK, Fla....

By Microdose

Press Releases

2 Mar 2021

PSYC Supports Launch of First Psychedelic Peer Support Program, Fireside Project, Through Sponsorship Commitment

PSYC to Contribute to First of Its Kind 24/7 Psychedelic Peer Support Hotline LAS VEGAS, NV, March 02, 2021 (GLOBE NEWSWIRE) — Global Trac Solutions, Inc....

By Microdose

Press Releases

2 Mar 2021

Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update

Significant progress made as Numinus-sponsored PRIME study on psilocybin-assisted psychotherapy for opioid, stimulant and/or alcohol use disorders enters pre-implementation stage VANCOUVER, BC, March 2, 2021 /CNW/ - Numinus Wellness Inc....

By Microdose

Press Releases

2 Mar 2021

Awakn Announces Exclusive License Deal with the University of Exeter to Commercialise the ‘Ketamine in the Reduction of Alcoholic Relapse’ (KARE) Intervention Validated in a Phase II Clinical Trial

London, United Kingdom-(Newsfile Corp....

By Microdose

Press Releases

2 Mar 2021

NeonMind Files Four Additional Provisional Patents on Psilocybin Preclinical Data

Vancouver, British Columbia–(Newsfile Corp....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result